Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients
- 5 November 2003
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 54 (6) , 828-831
Abstract
In this prospective study of 73 relapsing remitting multiple sclerosis patients followed up for a mean of 1.7 years, the relation was tested between serologically defined Chlamydia pneumoniae (CP) infection periods and exacerbation rate. Episodes of serologically defined CP infections were observed in a subgroup, and these episodes were associated with increased risk for exacerbation. CP polymerase chain reaction was positive in most of the CP seropositive patients. No correlation was found between the anti–CP antibody increase and titers of control antibodies.Keywords
This publication has 20 references indexed in Scilit:
- Chlamydia pneumoniae Infection of the Central Nervous System Worsens Experimental Allergic EncephalitisJournal of Experimental Medicine, 2002
- Sensitivity and specificity of three new commercially available Chlamydia trachomatis testsInternational Journal of STD & AIDS, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Multiple SclerosisNew England Journal of Medicine, 2000
- Evidence of 2 Waves of Chlamydia pneumoniae Infection in Gävle, Sweden,1990-96Scandinavian Journal of Infectious Diseases, 1999
- Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA959Journal of Medical Microbiology, 1997
- Influence of infection on exacerbations of multiple sclerosisAnnals of Neurology, 1994
- Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in FinlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Spread of Subclinical Chlamydia pneumoniae Infection in a Closed CommunityScandinavian Journal of Infectious Diseases, 1992
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965